Doctor profile · Federal record
Dr. Stacy Beaty, MD
Dermatology Physician (CMS: Dermatology) · St Louis, MO
- NPI 1669499638
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1755 S Grand
St Louis, MO 63104
(314) 256-3433
fax (314) 256-3431 - Mailing address
-
3691 Rutger Ave, Provider Enrollment
St Louis, MO 63110
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Missouri #2005004429
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669499638. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,555
Distinct HCPCS
10
Medicare allowed
$110,412
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 370 | 75 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 359 | 295 | $89 | |
17110 |
Destruction of skin growth, 1-14 growths | 183 | 143 | $112 | |
17000 |
Destruction of precancer skin growth, 1 growth | 130 | 107 | $56 | |
11102 |
Biopsy of related skin growth, first growth | 120 | 102 | $94 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 111 | 88 | $124 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 58 | 14 | $1 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 47 | 47 | $110 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 39 | 39 | $56 | |
17111 |
Destruction of skin growth, 15 or more growths | 31 | 25 | $132 |
In context: peer comparison
Among 2 peers in St Louis Dermatology Physician, average services per provider: 118. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$1,932
Transactions
104
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 45 | $624.75 | |
| Abbvie INC. | 8 | $230.23 | |
| Amgen INC. | 10 | $181.44 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $167.07 | |
| Lilly USA, LLC | 5 | $116.86 | |
| Genzyme Corporation | 4 | $104.35 | |
| Incyte Corporation | 4 | $95.40 | |
| Novartis Pharmaceuticals Corporation | 3 | $90.40 | |
| Pfizer INC. | 5 | $82.99 | |
| Regeneron Healthcare Solutions, INC. | 3 | $67.70 | |
| Ucb, INC. | 3 | $65.52 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $43.09 | |
| Sun Pharmaceutical Industries INC. | 1 | $26.60 | |
| Strata Skin Sciences, INC. | 1 | $21.95 | |
| Tempus Ai, INC | 1 | $13.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
328
Patients
153
Total drug cost
$11,504
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocortisone | Generic | 56 | 28 | $502 |
| Doxycycline Hyclate | Generic | 48 | 19 | $2,502 |
| Ketoconazole | Generic | 47 | 24 | $1,518 |
| Triamcinolone Acetonide | Generic | 44 | 31 | $444 |
| Hydroxyzine Hcl | Generic | 26 | 0 | $359 |
| Clobetasol Propionate | Generic | 23 | 16 | $1,794 |
| Fluocinonide | Generic | 22 | 11 | $917 |
| Metronidazole | Generic | 22 | 12 | $1,717 |
| Cephalexin | Generic | 15 | 12 | $128 |
| Tretinoin | Generic | 14 | 0 | $1,393 |
Frequently asked questions
What is Dr. Stacy Beaty's medical specialty?
Dr. Stacy Beaty practices Dermatology Physician in St Louis, MO.
Where does Dr. Stacy Beaty practice?
Dr. Stacy Beaty practices at 1755 S Grand, St Louis, MO 63104. Office phone: 3142563433.
What is Dr. Stacy Beaty's NPI?
Dr. Stacy Beaty's National Provider Identifier (NPI) is 1669499638, issued by NPPES.
Does Dr. Stacy Beaty accept Medicare assignment?
Yes. Dr. Stacy Beaty accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stacy Beaty commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.